Detailed information for compound 142668

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 315.278 | Formula: C16H13NO6
  • H donors: 3 H acceptors: 4 LogP: 0.79 Rotable bonds: 3
    Rule of 5 violations (Lipinski): 1
  • SMILES: COc1cc2c(cc1OC)[nH]cc2C1=C(O)C(=CC(=O)C1=O)O
  • InChi: 1S/C16H13NO6/c1-22-12-3-7-8(6-17-9(7)4-13(12)23-2)14-15(20)10(18)5-11(19)16(14)21/h3-6,17-18,20H,1-2H3
  • InChiKey: UWYULHKRFBNKAA-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Chlamydia trachomatis phosphoshikimate 1-carboxyl vinyltransferase 0.2181 0.9004 1
Schistosoma mansoni 3-dehydroquinate synthase 0.0849 0.2766 0.2602
Trypanosoma cruzi protein farnesyltransferase alpha subunit, putative 0.0621 0.1697 1
Echinococcus granulosus protein prenyltransferase alpha subunit 0.0621 0.1697 0.1508
Mycobacterium tuberculosis 3-dehydroquinate synthase AroB 0.0849 0.2766 0.5
Entamoeba histolytica protein farnesyltransferase alpha subunit, putative 0.2394 1 1
Trypanosoma brucei Protein prenyltransferase alpha subunit repeat, putative 0.0621 0.1697 1
Plasmodium falciparum protein farnesyltransferase subunit alpha 0.2394 1 1
Trichomonas vaginalis protein farnesyltransferase alpha subunit, putative 0.0621 0.1697 0.1508
Chlamydia trachomatis UDP-N-acetylglucosamine 1-carboxyvinyltransferase 0.1332 0.5028 0.3627
Plasmodium vivax prenyltransferase alpha subunit, putative 0.2394 1 1
Echinococcus granulosus protein farnesyltransferase alpha subunit 0.2394 1 1
Trypanosoma cruzi protein farnesyltransferase alpha subunit, putative 0.0621 0.1697 1
Mycobacterium ulcerans 3-phosphoshikimate 1-carboxyvinyltransferase 0.2181 0.9004 1
Wolbachia endosymbiont of Brugia malayi UDP-N-acetylglucosamine 1-carboxyvinyltransferase 0.1332 0.5028 0.5
Schistosoma mansoni protein farnesyltransferase alpha subunit 0.2394 1 1
Trypanosoma cruzi hypothetical protein, conserved 0.0621 0.1697 1
Trypanosoma brucei Protein prenyltransferase alpha subunit repeat, putative 0.0621 0.1697 1
Loa Loa (eye worm) prenyltransferase alpha subunit repeat containing protein 0.2394 1 1
Mycobacterium tuberculosis 3-phosphoshikimate 1-carboxyvinyltransferase AroA (5-enolpyruvylshikimate-3-phosphate synthase) (EPSP synthase) (EPSPS) 0.0849 0.2766 0.5
Onchocerca volvulus 0.0621 0.1697 0.5
Toxoplasma gondii hypothetical protein 0.1773 0.7094 0.7386
Trypanosoma cruzi hypothetical protein, conserved 0.0621 0.1697 1
Giardia lamblia Rab geranylgeranyltransferase 0.2394 1 1
Loa Loa (eye worm) prenyltransferase alpha subunit repeat containing protein 0.0621 0.1697 0.1508
Mycobacterium leprae probable 3-phosphoshikimate 1-carboxyvinyl transferase AroA (5-ENOLPYRUVYLSHIKIMATE-3-PHOSPHATE SYNTHASE) (EPSP SYNTHASE) (EPSPS 0.2181 0.9004 1
Leishmania major protein farnesyltransferase alpha subunit, putative 0.0621 0.1697 1
Trypanosoma brucei hypothetical protein, conserved 0.0621 0.1697 1
Trichomonas vaginalis protein farnesyltransferase alpha subunit, putative 0.2394 1 1
Trypanosoma brucei protein farnesyltransferase alpha subunit, putative 0.0621 0.1697 1
Trichomonas vaginalis protein farnesyltransferase alpha subunit/RAB geranylgeranyl transferase alpha subunit, putative 0.2394 1 1
Trichomonas vaginalis protein farnesyltransferase alpha subunit, putative 0.2394 1 1
Treponema pallidum UDP-N-acetylglucosamine 1-carboxyvinyltransferase 0.1332 0.5028 0.5
Echinococcus multilocularis protein farnesyltransferase alpha subunit 0.2394 1 1
Echinococcus granulosus geranylgeranyl transferase type 2 subunit alpha 0.0621 0.1697 0.1508
Echinococcus multilocularis protein prenyltransferase alpha subunit 0.0621 0.1697 0.1508
Trichomonas vaginalis protein farnesyltransferase alpha subunit/RAB geranylgeranyl transferase alpha subunit, putative 0.1773 0.7094 0.7028
Loa Loa (eye worm) hypothetical protein 0.2394 1 1
Mycobacterium ulcerans UDP-N-acetylglucosamine 1-carboxyvinyltransferase 0.1332 0.5028 0.3627
Brugia malayi Protein prenyltransferase alpha subunit repeat containing protein 0.0621 0.1697 0.1508
Entamoeba histolytica Rab geranylgeranyltransferase alpha subunit, putative 0.0621 0.1697 0.1508
Echinococcus multilocularis geranylgeranyl transferase type 2 subunit alpha 0.0621 0.1697 0.1508
Toxoplasma gondii shikimate dehydrogenase substrate binding domain-containing protein 0.2181 0.9004 1
Trypanosoma cruzi Protein prenyltransferase alpha subunit repeat, putative 0.0621 0.1697 1
Schistosoma mansoni rab geranylgeranyl transferase alpha subunit 0.0621 0.1697 0.1508

Activities

Activity type Activity value Assay description Source Reference
Inhibition (binding) = 19 % Percent inhibition of cell division cycle 25B at 50 microM. ChEMBL. 12801222
Inhibition (binding) = 19 % Percent inhibition of cell division cycle 25B at 50 microM. ChEMBL. 12801222
Inhibition (binding) = 20 % Percent inhibition of cell division cycle 25 degree C at 50 microM. ChEMBL. 12801222
Inhibition (binding) = 20 % Percent inhibition of cell division cycle 25 degree C at 50 microM. ChEMBL. 12801222
Inhibition (binding) = 54 % Percent inhibition of cell division cycle 25A at 50 microM. ChEMBL. 12801222
Inhibition (binding) = 54 % Percent inhibition of cell division cycle 25A at 50 microM. ChEMBL. 12801222

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.